CRYOCYTE FREEZING CONTAINER 500 ML W/LABEL POCKET R4R9955

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a 01,05 report with the FDA on 2008-08-26 for CRYOCYTE FREEZING CONTAINER 500 ML W/LABEL POCKET R4R9955 manufactured by Baxter Healthcare.

Event Text Entries

[931630] The customer contacted company to report an adverse event that occurred with a pt who received blood product from a cryocyte freezing container. Transfusion was commenced using a pooled sample including two frozen/thawed cd34 selected products and five units of frozen/thawed donor original bone marrow. Total volume transfused was 660ml cd34 dose was 3. 67x106/kg. Dmso amount was 1. 14g/kg. The physician involved described this event as an adverse reaction to stem cell infusion/dmso, complicated by hypertensive crisis, subarachnoid hemorrhage, pulmonary edema, and acute renal impairment hemolysis. The pt has been stabilized but has a low white cell count and is still hospitalized. Per the attachments obtained from miltenyi biotec inc, there was no cryocyte container failure, defect or breakage involved with this incident. Add'l info received on 08/05/08 provided a timeline of the events which is as follows: 1130-infusion commenced, the pt experienced chest tightness, bp 130/80-160/110. Atenolol 25mg was given. At 1400, the infusion was completed. At 1445, the pt experienced hypoxia and had crackles in the left mid-zone of the lung. The bp was 220/120. The bp then dropped from 190/120 to 160/110. High dose oxygen support was given in addition to furosemide 40mg iv, amlodipine, and then furosemide 40mg iv once again. At 1500, the pt's urine was blood stained. At 1600, a chest x-ray showed patchy infiltration of both lower zones of the lungs. Methylprednisone was given 1mg/kg. The pt had a moderate headache. A ct of the brain showed extensive subarachnoid hemorrhage for which a platelet, rfactor vii transfusion was given. The pt's creatinine was 152umol/l, the ldh was 4010u/l, and the total bilirubin was 109umol/l.
Patient Sequence No: 1, Text Type: D, B5


[8108573] The samples are not available for eval as they were discarded by the customer. Reportedly, there was no visible product defect on any of the cryocyte containers involved.
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number1423500-2008-00772
MDR Report Key1136706
Report Source01,05
Date Received2008-08-26
Date of Report2008-08-01
Date of Event2008-06-23
Date Mfgr Received2008-08-01
Date Added to Maude2008-09-08
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Reporter OccupationMEDICAL TECHNOLOGIST
Health Professional3
Initial Report to FDA3
Report to FDA0
Event Location0
Manufacturer ContactKAREN KIRBY, MGR
Manufacturer Street25212 W. ILLINOIS RTE 120
Manufacturer CityROUND LAKE IL 60073
Manufacturer CountryUS
Manufacturer Postal60073
Manufacturer Phone8472704541
Manufacturer G1BAXTER HEALTHCARE CORPORATION
Manufacturer Street1900 HIGHWAY 201 NORTH
Manufacturer CityMOUNTAIN HOME AR 72653249
Manufacturer CountryUS
Manufacturer Postal Code72653 2497
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameCRYOCYTE FREEZING CONTAINER 500 ML W/LABEL POCKET
Generic Name81KSE
Product CodeKSE
Date Received2008-08-26
Catalog NumberR4R9955
Lot NumberH07I29029
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device AgeDA
Device Eval'ed by MfgrR
Implant FlagN
Date RemovedB
Device Sequence No1
Device Event Key1163879
ManufacturerBAXTER HEALTHCARE
Manufacturer AddressMOUNTAIN HOME AR US


Patients

Patient NumberTreatmentOutcomeDate
101. Hospitalization; 2. Required No Informationntervention 2008-08-26

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.